Chemed Corp.

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: US16359R1032
USD
424.30
-6.53 (-1.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Chemed Corp. stock-summary
stock-summary
Chemed Corp.
Hospital
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.
Company Coordinates stock-summary
Company Details
255 E 5th St Ste 2600 , CINCINNATI OH : 45202-4138
stock-summary
Tel: 1 513 7626690
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 125 Schemes (40.74%)

Foreign Institutions

Held by 223 Foreign Institutions (17.78%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. George Walsh
Independent Chairman of the Board
Mr. Kevin McNamara
President, Chief Executive Officer, Director
Mr. Thomas Hutton
Director
Mr. Joel Gemunder
Independent Director
Mr. Patrick Grace
Independent Director
Mr. Walter Krebs
Independent Director
Dr. Andrea Lindell
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
619 Million
(Quarterly Results - Jun 2025)
Net Profit:
52 Million
stock-summary
Industry

Hospital

stock-summary
Market cap

USD 16,532 Million (Small Cap)

stock-summary
P/E

65.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.19%

stock-summary
Debt Equity

-0.17

stock-summary
Return on Equity

24.24%

stock-summary
Price to Book

13.79